These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 797334)

  • 1. [Intracellular organisation of bacteriophage tail-like bacteriocins of group A in Serratia marcescens (author's transl)].
    Acker G
    Arch Microbiol; 1976 Dec; 111(1-2):175-83. PubMed ID: 797334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on group A (phage tail) bacteriocins of Serratia marcescens. I. Phenotypic variation of producer and indicator strains.
    Traub WH; Kleber I
    Zentralbl Bakteriol Orig A; 1973 Dec; 225(2):296-304. PubMed ID: 4150063
    [No Abstract]   [Full Text] [Related]  

  • 3. Epidemiological differentiation of Serratia marcescens: typing by bacteriocin sensitivity.
    Farmer JJ
    Appl Microbiol; 1972 Feb; 23(2):226-31. PubMed ID: 4552885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic evidence for an activator required for induction of colicin-like bacteriocin 28b production in Serratia marcescens by DNA-damaging agents.
    Ferrer S; Viejo MB; Guasch JF; Enfedaque J; Regué M
    J Bacteriol; 1996 Feb; 178(4):951-60. PubMed ID: 8576068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study on bacteriocin (marcescin) typing of Serratia marcescens. I. Fundamental studies on bacteriocin (marcescin) production and sensitivity (author's transl)].
    Nasu M
    Kansenshogaku Zasshi; 1977 Sep; 51(9):487-98. PubMed ID: 416153
    [No Abstract]   [Full Text] [Related]  

  • 6. Bacteriocin (Marcescin) typing of clinical isolates of Serratia marcescens.
    Traub WH; Raymond EA; Startsman TS
    Appl Microbiol; 1971 May; 21(5):837-40. PubMed ID: 4930037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of nalidixic acid, rifampicin and chloramphenicol on the mitomycin C--induced synthesis of a bacteriocin of Serratia marcescens.
    Eichenlaub R; Winkler U
    Biochem Biophys Res Commun; 1974 Jul; 59(1):133-9. PubMed ID: 4601812
    [No Abstract]   [Full Text] [Related]  

  • 8. Continued surveillance of Serratia marcescens infections by bacteriocin typing: investigation of two outbreaks of cross-infection in an intensive care unit.
    Traub WH
    Appl Microbiol; 1972 May; 23(5):982-5. PubMed ID: 4555641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacteriocin (marcescin) typing of clinically isolated Serratia marcescens.
    Nasu M
    Tohoku J Exp Med; 1981 Jan; 133(1):33-43. PubMed ID: 7015560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of group A bacteriocins of Serratia marcescens by nalidixic acid.
    Traub WH; Kleber I; Schaber I
    Nat New Biol; 1973 Oct; 245(144):144-5. PubMed ID: 4582895
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on group A (phage tail) bacteriocins of Serratia marcescens. V. Serological characterization of subgroup I and II bacteriocins.
    Traub WH; Kleber I
    Zentralbl Bakteriol Orig A; 1976 May; 234(4):521-7. PubMed ID: 779357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological differentiation of Serratia marcescens: typing by bacteriocin production.
    Farmer JJ
    Appl Microbiol; 1972 Feb; 23(2):218-25. PubMed ID: 4552884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of two methods for bacteriocin typing of Serratia marcescens.
    Lai PS; Ngeow YF; Puthucheary SD; Wang CW
    J Clin Microbiol; 1983 Jan; 17(1):1-6. PubMed ID: 6338029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bacteriocin (marcescin) typing of Serratia marcescens. II. The distribution of Serratia marcescens in hospital and its isolated cases by bacteriocin (marcescin) typing (author's transl)].
    Nasu M
    Kansenshogaku Zasshi; 1978 Jun; 52(6):183-9. PubMed ID: 101627
    [No Abstract]   [Full Text] [Related]  

  • 15. Isolation and characterization of a bacteriophage tail-like bacteriocin from a strain of Rhizobium.
    Lotz W; Mayer F
    J Virol; 1972 Jan; 9(1):160-73. PubMed ID: 4110105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and partial characterization of a bacteriocin from Serratia marcescens.
    Foulds J
    J Bacteriol; 1972 Jun; 110(3):1001-9. PubMed ID: 4555400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant synthesis of bacteriocin and bacteriocin inactivator from Serratia marcescens.
    Foulds JD; Shemin D
    J Bacteriol; 1969 Sep; 99(3):661-6. PubMed ID: 4905531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Properties and characteristics of a bacteriocin from Serratia marcescens.
    Foulds JD; Shemin D
    J Bacteriol; 1969 Sep; 99(3):655-60. PubMed ID: 4905530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of a bacteriophage, a phage tail-like bacteriocin and an antibiotic by Bacillus azotofixans.
    Seldin L; Penido EG
    An Acad Bras Cienc; 1990 Mar; 62(1):85-94. PubMed ID: 2129100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Products of defective lysogeny in Serratia marcescens SMG 38 and their activity against Escherichia coli and other Enterobacteria.
    Gratia JP
    J Gen Microbiol; 1989 Jan; 135(1):25-35. PubMed ID: 2674324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.